glp-1 drug prices The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Administration announces deal to lower
Description
The glucagon receptor activation is the key differentiator
PMID: 38598580
Importantly Exendin-4 has a mutation that blocks its cleavage extending its half-life to 2.4 h
2022 doi: 10.1111/dom.14948
P = 0.02
Post-marketing surveillance and observational studies have yielded mixed results, though the absolute risk appears very low given the rarity of MTC
